A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
A study of Lumigan® 0.01% as administered in standard practice for patients with POAG or OHT.
All treatment decisions, care and diagnostic procedures provided are at the discretion of the
participating physicians according to their clinical judgment and the local standard of
medical care.